http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Obesity phenotype and cardiovascular changes
Park, Juri,Kim, Seong H.,Cho, Goo-Yeong,Baik, Inkyung,Kim, Nan H.,Lim, Hong E.,Kim, Eung J.,Park, Chang G.,Lim, Sang Y.,Kim, Yong H.,Kim, Hyun,Lee, Seung K.,Shin, Chol Lippincott Williams Wilkins, Inc. 2011 Journal of Hypertension Vol.29 No.9
OBJECTIVE: Healthy obese phenotype with favorable metabolic profiles is proposed. However, whether healthy obesity leads to target organ changes is controversial. We investigated the impact of a healthy obesity on cardiovascular structure and function. METHODS: A total of 2540 participants without known cardiovascular disease were enrolled. According to BMI and the metabolic syndrome (MetS) component, the participants were divided into six groups: healthy (none of five MetS components) normal weight (BMI <23 kg/m), unhealthy (one or more of five MetS components) normal weight, healthy overweight (BMI 23–24.9 kg/m), unhealthy overweight, healthy obesity (BMI ≥25 kg/m), and unhealthy obesity. The cardiovascular changes were assessed by echocardiography, tissue Doppler imaging (TDI), carotid ultrasonography, and pulse wave velocity (PWV). RESULTS: In a multivariate analysis after adjusting for age, sex, heart rate, high-sensitivity C-reactive protein, and medication for hypertension and diabetes mellitus, the unhealthy overweight and obese groups showed statistically significant changes in the left ventricular mass index, mitral E/A ratio, E/Ea ratio, TDI Ea velocity, common carotid artery intima–media thickness (CCA-IMT), and brachial-ankle PWV (P < 0.001), compared with the healthy normal weight individuals. In the healthy overweight and obese groups, CCA-IMT and brachial-ankle PWV values were similar, but left-ventricular mass index and TDI Ea velocity were significantly different (P < 0.001). CONCLUSION: Healthy obesity was associated with subtle changes in left ventricular structure and function. These data provide evidence that metabolically healthy phenotypes with excess weight may not be a benign condition.
Effect of combined anti-PD-1 and temozolomide therapy in glioblastoma
Park, Junseong,Kim, Chang Gon,Shim, Jin-Kyoung,Kim, Jong Hoon,Lee, Hoyoung,Lee, Jae Eun,Kim, Min Hwan,Haam, Keeok,Jung, Inkyung,Park, Su-Hyung,Chang, Jong Hee,Shin, Eui-Cheol,Kang, Seok-Gu Informa UK (TaylorFrancis) 2019 Oncoimmunology Vol.8 No.1
Choi Baekgyu,Kang Chang Kyung,Park Seongwan,Lee Dohoon,Lee Andrew J.,Ko Yuji,Kang Suk-Jo,Kang Kyuho,Kim Sun,Koh Youngil,Jung Inkyung 생화학분자생물학회 2022 Experimental and molecular medicine Vol.54 No.-
Clonal hematopoiesis of indeterminate potential (CHIP), a common aging-related process that predisposes individuals to various inflammatory responses, has been reported to be associated with COVID-19 severity. However, the immunological signature and the exact gene expression program by which the presence of CHIP exerts its clinical impact on COVID-19 remain to be elucidated. In this study, we generated a single-cell transcriptome landscape of severe COVID-19 according to the presence of CHIP using peripheral blood mononuclear cells. Patients with CHIP exhibited a potent IFN-γ response in exacerbating inflammation, particularly in classical monocytes, compared to patients without CHIP. To dissect the regulatory mechanism of CHIP (+)-specific IFN-γ response gene expression in severe COVID-19, we identified DNMT3A CHIP mutation-dependent differentially methylated regions (DMRs) and annotated their putative target genes based on long-range chromatin interactions. We revealed that CHIP mutant-driven hypo-DMRs at poised cis-regulatory elements appear to facilitate the CHIP (+)-specific IFN-γ-mediated inflammatory immune response. Our results highlight that the presence of CHIP may increase the susceptibility to hyperinflammation through the reorganization of chromatin architecture, establishing a novel subgroup of severe COVID-19 patients.